German manufacturer Gerresheimer said it will launch a new integrated, passive syringe safety solution to the pharma and healthcare sectors.
The company acquired an exclusive license for the syringe safety solution from West Pharmaceutical Services.
It is said to complete Gerresheimer’s product portfolio of prefillable syringes made of glass and plastics.
The new safety solution is also fully compatible with the company’s RTF (ready-to-fill) syringe portfolio.
Gerresheimer CEO Uwe Röhrhoff said: “As a result of our long-standing partnership with the leading manufacturer of packaging components and delivery devices for parenteral drugs we are pleased to have acquired the rights to market this innovative, new syringe safety solution, developed by West.
“By doing so, we will complement our very broad range of prefillable syringe solutions for biotech and other drugs.”
Claimed to be fully integrated, the syringe safety solution will be assembled on the syringe in the run of the RTF production process.
According to Gerresheimer, the syringe safety solution is compliant with standard nests and tubs. This, it says allows pharmaceutical companies to use the standard filling process.
The integrated safety syringe is expected to address the high number of needlestick-related injuries sustained by healthcare workers through its enhanced syringe processability and high-end user friendliness.
Gerresheimer supplies specialty glass and plastic products to the pharma and healthcare industry across the world and has a workforce of around 10,000 employees.
Its product portfolio features pharmaceutical packaging and products for the safe, simple administration of medicines like inhalers, prefillable syringes, insulin pens, ampoules, injection vials, bottles and containers for solid and liquid medicines having closure and safety systems.
Gerresheimer maintains manufacturing plants across Europe, Asia, North America and South America and has revenues of about €1.4bn.
